Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Title
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
Authors
Keywords
Nivolumab, Pembrolizumab, Treatment failure, Efficacy, Ipilimumab, Ipilimumab and nivolumab, Melanoma, Disease progression, Anti-PD-1
Journal
EUROPEAN JOURNAL OF CANCER
Volume 75, Issue -, Pages 47-55
Publisher
Elsevier BV
Online
2017-02-17
DOI
10.1016/j.ejca.2017.01.009

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now